The U.S. needs to reimagine its pharma supply chain
Image by
MirageC/Getty Images
Groups make own drugs to fight high prices, shortages: ‘It’s been a real game changer’
“The pandemic has only exacerbated a previously existing problem: U.S. dependence on foreign manufacturers of drug ingredients and finished products that has resulted in shortages of critical medicines. The remedy is to create a domestic manufacturing capability, adopt new production technologies, and change what’s kept in the Strategic National Stockpile. This will require a partnership between the public and private sectors.”